Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil Abraham Joy

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 10, 2017
Targeting HER2 in Advanced Breast CancerXiaofu Zhu, Anil Abraham Joy
Seminars in Oncology Nursing|July 26, 2021
Advanced Cancer as a Chronic Disease: IntroductionEdith Pituskin, Anil Abraham Joy, Alysa Fairchild
Canadian Journal of Surgery. Journal Canadien De Chirurgie|February 29, 2020
Unwarranted imaging for distant metastases in patients with newly diagnosed ductal carcinoma in situ and stage I and II breast cancerSasha Lupichuk, Derek Tilley, Brae Surgeoner, et al.
The Oncologist|June 6, 2019
Why "Reply All" Can Push All the Wrong ButtonsSharon McGee, Mark Clemons, Anil Abraham Joy, et al.
Therapeutic Advances in Medical Oncology|October 5, 2020
Positive progress: current and evolving role of immune checkpoint inhibitors in metastatic triple-negative breast cancerChristine E Simmons, Christine Brezden-Masley, Joy McCarthy, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian PerspectiveCristiano Ferrario, Anna Christofides, Anil Abraham Joy, et al.
Therapeutic Advances in Medical Oncology|June 16, 2023
Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigmCharlie Yang, Christine Brezden-Masley, Anil Abraham Joy, et al.
Clinical Breast Cancer|September 3, 2018
Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerVered Stearns, Adam M Brufsky, Shailendra Verma, et al.
The Oncologist|February 12, 2017
Predatory Invitations from Journals: More Than Just a Nuisance?Mark Clemons, Miguel de Costa E Silva, Anil Abraham Joy, et al.
Cureus|December 3, 2016
Factors Associated With the Use of Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer in Alberta, Canada: A Population-based StudyHong-Wei Liu, Marc Kerba, Gerald Lim, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|August 10, 2017
Targeting HER2 in Advanced Breast CancerXiaofu Zhu, Anil Abraham Joy
Seminars in Oncology Nursing|July 26, 2021
Advanced Cancer as a Chronic Disease: IntroductionEdith Pituskin, Anil Abraham Joy, Alysa Fairchild
Canadian Journal of Surgery. Journal Canadien De Chirurgie|February 29, 2020
Unwarranted imaging for distant metastases in patients with newly diagnosed ductal carcinoma in situ and stage I and II breast cancerSasha Lupichuk, Derek Tilley, Brae Surgeoner, et al.
The Oncologist|June 6, 2019
Why "Reply All" Can Push All the Wrong ButtonsSharon McGee, Mark Clemons, Anil Abraham Joy, et al.
Therapeutic Advances in Medical Oncology|October 5, 2020
Positive progress: current and evolving role of immune checkpoint inhibitors in metastatic triple-negative breast cancerChristine E Simmons, Christine Brezden-Masley, Joy McCarthy, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian PerspectiveCristiano Ferrario, Anna Christofides, Anil Abraham Joy, et al.
Therapeutic Advances in Medical Oncology|June 16, 2023
Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigmCharlie Yang, Christine Brezden-Masley, Anil Abraham Joy, et al.
Clinical Breast Cancer|September 3, 2018
Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerVered Stearns, Adam M Brufsky, Shailendra Verma, et al.
The Oncologist|February 12, 2017
Predatory Invitations from Journals: More Than Just a Nuisance?Mark Clemons, Miguel de Costa E Silva, Anil Abraham Joy, et al.
Cureus|December 3, 2016
Factors Associated With the Use of Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer in Alberta, Canada: A Population-based StudyHong-Wei Liu, Marc Kerba, Gerald Lim, et al.
Pageof 4